The choice of the nucleoside backbone in initial therapy.
Gallant
Joel E
JE
D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D009690:Nucleic Acid Conformation; D009711:Nucleotides / Q000737:chemistry*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000737:chemistry* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use
D009711:Nucleotides; D018894:Reverse Transcriptase Inhibitors